Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close HY23 trading update

27 Mar 2023 07:00

RNS Number : 2289U
Hyve Group PLC
27 March 2023
 

27 March 2023

 

Hyve Group plc

 

("Hyve" or the "Group")

 

Pre-close HY23 trading update

 

Trading in line with the Group's expectations, including the reopening of China

 

Hyve Group plc, the next-generation global events business, today announces a trading update for the period from 1 October 2022 to 26 March 2023.

 

The Group has successfully run a full schedule of events in the reporting period and is expected to deliver revenue for HY23 in a range of £95m - £100m underpinned by another strong performance across all key KPIs including like-for-like customer spend.

 

Following its five-year transformation, which completed in FY22, the schedule of the Group's streamlined portfolio of market leading events is now weighted to the first half of its financial year. This includes brands such as Africa Oil Week, Mining Indaba, Spring Fair, which all delivered strong year on year growth. Fintech Meetup and Shoptalk, both taking place at the end of March, are expected to perform in line with the Group's expectations, despite some impact on attendance from the uncertainties created as a result of recent macro events in the Banking and Technology sectors.

 

Following the phasing out of COVID-19 related restrictions, the Group was able to hold its first events in China since 2020, including ChinaCoat. As expected, the events were impacted due to early stages of market re-opening and the lack of international participation.

 

Good progress has been made in rolling out the meeting programmes offering across the portfolio. The Group continues to invest significantly into these products not only to cement the events' market-leading status, and increase ROI for customers, but also to drive future organic growth.

 

Net debt and Insurance

Adjusted net debt at 22 March 2023 was approximately £55m[1] (31 March 2022: £64m) which includes the receipt of insurance proceeds in February and bookings for upcoming events, but does not take into consideration recent event delivery costs. The adjusted net debt position at the end of FY23 is expected to be in the region of £80m-£85m.

 

The Group received a further £4.2m of cancellation insurance proceeds bringing aggregate claims to date to £110.5m out of £112m maximum available for events cancelled in FY20 and FY21. This was the final settlement amount in respect of all outstanding claims.

 

Forward bookings underpin confidence in FY23 expected outturn

 

The Group entered FY23 with positive trading momentum, which has continued throughout the first half of the year with forward bookings of approximately £145m as of 22 March, giving confidence that performance for the full financial year will be in line with the Group's expectations. At the same point in time last year the Group had £102m of forward bookings on FY22 events.

 

Mark Shashoua, CEO of Hyve Group plc, commented:

Our five-year transformation, which we completed last year and resulted in a streamlined and de-risked portfolio of market-leading events, has allowed us to start this year with purpose and momentum. This has led to strong trading throughout the first six months of the year, with like-for-like customer spend tracking strongly into FY23 in line with our expectations.

In addition, our digital diversification continues, with the addition of new tech-enabled meetings programmes and the expansion of existing ones. This trajectory will continue in the second half of the year.

We remain conscious of challenges in the macro-economic environment globally, the threat of recession in a number of our markets and, in particular, the recent macro events in Banking and Tech sectors. However, we believe we are well placed to weather any possible challenges, as marketing spend continues to gravitate towards must-attend leading events that drive return on investment.


[1] Adjusted net debt is defined as cash and cash equivalents after deducting bank loans.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFIMEDSEID
Date   Source Headline
2nd Feb 20215:15 pmRNSHolding(s) in Company
21st Jan 20213:44 pmRNSAnnouncement of Results of Annual General Meeting
21st Jan 20217:00 amRNSTrading Update
21st Dec 20205:55 pmRNSAcquisition of Retail Meetup
10th Dec 20203:52 pmRNSHolding(s) in Company
9th Dec 20204:06 pmRNSHolding(s) in Company
8th Dec 20201:54 pmRNSDirector/PDMR Shareholding
7th Dec 20205:37 pmRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSFinal Results
23rd Nov 20203:37 pmRNSHolding(s) in Company
13th Nov 202012:16 pmRNSHolding(s) in Company
4th Nov 20205:52 pmRNSHolding(s) in Company
4th Nov 20204:24 pmRNSHolding(s) in Company
22nd Oct 20207:00 amRNSHolding(s) in Company
20th Oct 20209:28 amRNSDirector Declaration
1st Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Sep 20203:19 pmRNSDirector Declaration
29th Sep 20207:00 amRNSHolding(s) in Company
28th Sep 202012:52 pmRNSHolding(s) in Company
25th Sep 20209:50 amRNSDirector/PDMR Shareholding
23rd Sep 20207:01 amRNSBoard Change
23rd Sep 20207:00 amRNSPre-close trading update and further cost savings
22nd Sep 20201:44 pmRNSHolding(s) in Company
24th Aug 202012:02 pmRNSPrice Monitoring Extension
30th Jul 20204:14 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSTrading Update
27th Jul 20209:00 amRNSHolding(s) in Company
21st Jul 20203:37 pmRNSDirector Declaration
14th Jul 20202:33 pmRNSDirector/PDMR Shareholding
10th Jul 20205:49 pmRNSHolding(s) in Company
7th Jul 20202:40 pmRNSHolding(s) in Company
7th Jul 20202:39 pmRNSHolding(s) in Company
2nd Jul 20203:37 pmRNSHolding(s) in Company
25th Jun 20202:52 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
19th Jun 20207:00 amRNSEvent schedule and insurance update
12th Jun 20202:38 pmRNSDirector/PDMR Shareholding
12th Jun 202010:37 amRNSResults of Rump Placing
12th Jun 20207:00 amRNSResults of Rights Issue
3rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20204:41 pmRNSPrice Monitoring Extension
28th May 20207:00 amRNSAdmission of Paid Rights, Share Consolidation, TVR
27th May 202010:31 amRNSResult of General Meeting
14th May 20207:00 amRNSAdditional Listing
7th May 20203:19 pmRNSANNOUNCEMENT OF PUBLICATION OF PROSPECTUS
7th May 202012:03 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSRights Issue & Agreement with Lenders
7th May 20207:00 amRNSINTERIM RESULTS ANNOUNCEMENT
24th Apr 20202:46 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Apr 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.